Yumi Kambayashi Selected Research

Interstitial Nephritis (Tubulointerstitial Nephritis)

5/2022

Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumi Kambayashi Research Topics

Disease

46	Melanoma (Melanoma, Malignant) 12/2023 - 11/2015
37	Neoplasms (Cancer) 04/2024 - 01/2012
10	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2024 - 01/2018
9	Mycosis Fungoides 01/2024 - 11/2013
8	Hemangiosarcoma (Angiosarcoma) 11/2023 - 01/2012
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 01/2015
4	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2021
4	Lymphoma (Lymphomas) 11/2022 - 01/2017
3	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2018 - 11/2012
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 09/2012
3	Carcinoma (Carcinomatosis) 01/2017 - 09/2012
2	Uveitis 12/2023 - 06/2018
2	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 12/2023 - 06/2018
2	Skin Neoplasms (Skin Cancer) 11/2023 - 01/2023
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2023 - 01/2020
2	Lymphomatoid Papulosis 01/2022 - 02/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2021 - 05/2012
2	Fever (Fevers) 01/2021 - 06/2020
2	Sarcoma (Soft Tissue Sarcoma) 09/2020 - 05/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 01/2019
2	Keratoacanthoma 01/2019 - 09/2017
2	Erythema 02/2018 - 09/2012
2	Bullous Pemphigoid (Pemphigoid) 01/2018 - 01/2014
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 01/2017
2	Pemphigus (Pemphigus Vulgaris) 01/2014 - 09/2013
1	Muscle Cramp (Cramp) 03/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2023
1	Lymphatic Metastasis 01/2023
1	Dermatofibrosarcoma 10/2022
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 05/2022
1	Rheumatoid Arthritis 05/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	COVID-19 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Drug Eruptions (Drug Eruption) 01/2022
1	Microcystic adnexal carcinoma 09/2021
1	Erythema Nodosum 11/2020
1	Adult-Onset Still's Disease 06/2020
1	Edema (Dropsy) 01/2020

Drug/Important Bio-Agent (IBA)

26	NivolumabIBA 01/2022 - 06/2016
13	IpilimumabIBA 09/2021 - 09/2016
11	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2018
10	AntibodiesIBA 08/2022 - 09/2017
10	trametinibIBA 05/2022 - 02/2018
10	dabrafenibIBA 05/2022 - 02/2018
9	Bexarotene (LGD1069)FDA Link 01/2024 - 01/2017
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 09/2017
8	ChemokinesIBA 01/2021 - 11/2015
7	pembrolizumabIBA 04/2024 - 01/2018
7	Immune Checkpoint InhibitorsIBA 09/2022 - 05/2017
5	Proto-Oncogene Proteins B-rafIBA 12/2023 - 01/2019
5	mogamulizumabIBA 11/2022 - 01/2018
5	Therapeutic UsesIBA 01/2020 - 11/2015
4	Plasminogen Activator Inhibitor 1IBA 01/2024 - 01/2021
4	Messenger RNA (mRNA)IBA 03/2023 - 11/2015
4	encorafenibIBA 05/2022 - 06/2020
4	binimetinibIBA 05/2022 - 06/2020
4	RetinoidsIBA 01/2022 - 11/2013
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 09/2012
4	Denosumab FDA Link 01/2020 - 01/2017
3	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2023 - 09/2019
3	taxaneIBA 07/2023 - 01/2023
3	Docetaxel (Taxotere)FDA Link 02/2023 - 01/2012
3	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 01/2018
3	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022 - 01/2018
3	Matrix Metalloproteinases (MMPs)IBA 09/2021 - 11/2012
3	PeriostinIBA 09/2021 - 01/2015
3	InterferonsIBA 01/2021 - 11/2013
3	RANK LigandIBA 01/2018 - 01/2016
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2024 - 11/2023
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2024 - 01/2012
2	HLA-DRB1*04 antigenIBA 12/2023 - 06/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 02/2023
2	PlasminogenIBA 01/2023 - 01/2021
2	AntigensIBA 09/2022 - 09/2020
2	Dacarbazine (DIC)FDA LinkGeneric 09/2020 - 01/2018
2	Histone Deacetylase InhibitorsIBA 09/2019 - 01/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2019 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2018
2	Imiquimod (Aldara)FDA LinkGeneric 01/2018 - 01/2017
2	PeplomycinIBA 01/2017 - 01/2015
2	dermcidinIBA 11/2013 - 09/2011
2	Diphosphonates (Bisphosphonates)IBA 01/2013 - 01/2012
2	Risedronic Acid (Actonel)FDA LinkGeneric 01/2013 - 01/2012
1	Plasminogen InactivatorsIBA 01/2024
1	DDTIBA 02/2023
1	Taxoids (Taxanes)IBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 10/2022
1	dupilumabIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 09/2020
1	Interferon Type IIBA 09/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020

Therapy/Procedure

51	Therapeutics 12/2023 - 09/2011
9	Immunotherapy 09/2022 - 06/2016
5	Radiotherapy 11/2022 - 01/2012
5	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2021 - 05/2017
4	Drug Therapy (Chemotherapy) 12/2023 - 01/2017
2	Phototherapy (Light Therapy) 06/2023 - 02/2018
2	Chemoradiotherapy 02/2023 - 01/2023